FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014367850> ?p ?o ?g. }

• W3014367850 endingPage "1126" @default.
• W3014367850 startingPage "1107" @default.
• W3014367850 abstract "Despite significant advances in cancer therapy, chemotherapeutic agents are still the main types of drugs used to treat cancer patients. 5-Fluorouracil (5-FU) is the first-line treatment in several types of human cancers, however, nonspecific function, low plasma half-life, and high doses toxicity are the important barrier to achieve efficient response in cancer patients. The use of polymeric nanoparticles (NPs) for tumor targeted delivery of 5-FU in combination with other potent anticancer agent is considered an important strategy to enhance the therapeutic efficacy of 5-FU. In this study, we proposed to use PLGA-PEG-PLGA NPs to co-encapsulate 5-FU and Chrysin, a natural compound known to enhance the therapeutic efficacy of chemotherapy. NPs were prepared by double emulsion method and characterized for size and drug encapsulation efficacy. The cell growth inhibitory effect of prepared NPs was assessed by MTT assay in HT29 human colon cancer cell line. The analysis of NPs by dynamic light scattering showed that the developed NPs have average size of 40 nm. The encapsulation efficiency of NPs was 81.3% and 97.5% for 5-FU and Chrysin, respectively. Furthermore, the NPs showed a remarkable uptake in HT29 cells. NPs loaded with both 5-FU and Chrysin (5-FU@Chrysin loaded NPs) were found to have significantly higher growth inhibitory effects compared with NPs loaded with each drug alone in HT29 cell line. The synergistic anticancer effects of 5-FU and Chrysin loaded in NPs were confirmed with the combination index (CI) being 0.35. CI for combination therapy with free 5-FU and Chrysin was found to be 0.73, indicating weaker synergistic anticancer effects of these two drugs in free forms as compared with 5-FU@Chrysin loaded NPs. These finding indicates that co-delivery of 5-FU and Chrysin with PLGA-PEG-PLGA copolymer can be used to improve the therapeutic and functional delivery efficacy of 5-FU and Chrysin in cancer." @default.
• W3014367850 created "2020-04-10" @default.
• W3014367850 creator A5005511441 @default.
• W3014367850 creator A5012257550 @default.
• W3014367850 creator A5035287813 @default.
• W3014367850 creator A5059325912 @default.
• W3014367850 creator A5069068292 @default.
• W3014367850 date "2020-04-05" @default.
• W3014367850 modified "2023-10-06" @default.
• W3014367850 title "Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin" @default.
• W3014367850 cites W1969330510 @default.
• W3014367850 cites W1969825132 @default.
• W3014367850 cites W1973645168 @default.
• W3014367850 cites W1991405375 @default.
• W3014367850 cites W1998282966 @default.
• W3014367850 cites W2007528450 @default.
• W3014367850 cites W2007755698 @default.
• W3014367850 cites W2008879251 @default.
• W3014367850 cites W2018263823 @default.
• W3014367850 cites W2020398834 @default.
• W3014367850 cites W2041694182 @default.
• W3014367850 cites W2044499234 @default.
• W3014367850 cites W2046574646 @default.
• W3014367850 cites W2061366118 @default.
• W3014367850 cites W2066601047 @default.
• W3014367850 cites W2071526079 @default.
• W3014367850 cites W2079479950 @default.
• W3014367850 cites W2080652879 @default.
• W3014367850 cites W2082445955 @default.
• W3014367850 cites W2082729702 @default.
• W3014367850 cites W2082868156 @default.
• W3014367850 cites W2084906235 @default.
• W3014367850 cites W2086534626 @default.
• W3014367850 cites W2092584246 @default.
• W3014367850 cites W2096439168 @default.
• W3014367850 cites W2103505011 @default.
• W3014367850 cites W2117142296 @default.
• W3014367850 cites W2128447158 @default.
• W3014367850 cites W2137121934 @default.
• W3014367850 cites W2143463421 @default.
• W3014367850 cites W2152546397 @default.
• W3014367850 cites W2216824414 @default.
• W3014367850 cites W2345952503 @default.
• W3014367850 cites W2471596032 @default.
• W3014367850 cites W2519307991 @default.
• W3014367850 cites W2528231206 @default.
• W3014367850 cites W2548892576 @default.
• W3014367850 cites W2552598605 @default.
• W3014367850 cites W2553849089 @default.
• W3014367850 cites W2594437595 @default.
• W3014367850 cites W2613332674 @default.
• W3014367850 cites W2737418044 @default.
• W3014367850 cites W2762341360 @default.
• W3014367850 cites W2781727981 @default.
• W3014367850 cites W2781860696 @default.
• W3014367850 cites W2790816472 @default.
• W3014367850 cites W2790866928 @default.
• W3014367850 cites W2804861259 @default.
• W3014367850 cites W2807823404 @default.
• W3014367850 cites W2885052946 @default.
• W3014367850 cites W2885216815 @default.
• W3014367850 cites W2899514116 @default.
• W3014367850 cites W2899700163 @default.
• W3014367850 cites W2902382293 @default.
• W3014367850 cites W2913850408 @default.
• W3014367850 cites W2914215092 @default.
• W3014367850 cites W2915528638 @default.
• W3014367850 cites W2921593822 @default.
• W3014367850 cites W2922360292 @default.
• W3014367850 cites W2935732657 @default.
• W3014367850 cites W2937018851 @default.
• W3014367850 cites W2939817433 @default.
• W3014367850 cites W2942224185 @default.
• W3014367850 cites W2944812490 @default.
• W3014367850 cites W2946277620 @default.
• W3014367850 cites W2946446720 @default.
• W3014367850 cites W2950596925 @default.
• W3014367850 cites W2950860419 @default.
• W3014367850 cites W2951071083 @default.
• W3014367850 cites W2957984348 @default.
• W3014367850 cites W2958932233 @default.
• W3014367850 cites W2964847469 @default.
• W3014367850 cites W2991337082 @default.
• W3014367850 doi "https://doi.org/10.1080/09205063.2020.1743946" @default.
• W3014367850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32249693" @default.
• W3014367850 hasPublicationYear "2020" @default.
• W3014367850 type Work @default.
• W3014367850 sameAs 3014367850 @default.
• W3014367850 citedByCount "46" @default.
• W3014367850 countsByYear W30143678502020 @default.
• W3014367850 countsByYear W30143678502021 @default.
• W3014367850 countsByYear W30143678502022 @default.
• W3014367850 countsByYear W30143678502023 @default.
• W3014367850 crossrefType "journal-article" @default.
• W3014367850 hasAuthorship W3014367850A5005511441 @default.
• W3014367850 hasAuthorship W3014367850A5012257550 @default.
• W3014367850 hasAuthorship W3014367850A5035287813 @default.
• W3014367850 hasAuthorship W3014367850A5059325912 @default.

• next